GGrantIndex
← Search

SRI TO5 - IND-Enabling GLP Toxicology Studies - BUCKPITT LDT

$1,714,190N01FY2018DANIH

Sri International, Menlo Park CA

Investigators

Abstract

Development of an Oral Analgesic for Neuropathic Pain. These studies support research related to the development of opioid alternatives and the NIH Helping to End Addiction Long-term (HEAL) Initiative.

View original record on NIH RePORTER →
SRI TO5 - IND-Enabling GLP Toxicology Studies - BUCKPITT LDT · GrantIndex